Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Site Tools

  • AAAS
  • Subscribe
  • Feedback

Site Search

Search Advanced

Science 24 November 2000:
Vol. 290. no. 5496, p. 1508
DOI: 10.1126/science.290.5496.1508
Prev | Table of Contents | Next

Policy Forum

INFECTIOUS DISEASE:
The Case for Deemphasizing Genomics in Malaria Control

C. F. Curtis

Solving the enormous problem of malaria worldwide will require a balance between investments in research and control. In this point-counterpoint, two scientists describe the rationales for these very different strategies. Steve Hoffman believes that genomics research is the best investment in the future if we have the vision of malaria eradication. Chris Curtis presents an opposing viewpoint, that low-tech control approaches are the practical ones under current conditions.

The author is at the London School of Hygiene & Tropical Medicine, London WC1E 7HT, U.K. E-mail: chris.curtis{at}lshtm.ac.uk

This policy forum is based on the authors' contribution to a debate at a meeting at Oxford University organized by the Royal Society of Tropical Medicine and Hygiene and sister societies.

Read the Full Text

ADVERTISEMENT
Click Me!

ADVERTISEMENT
Click Me!

To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)